Liangdong Song
Chongqing, 400016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Loss of biomechanical features reveals smooth muscle disruption and disease progression in prostate cancer.
Journal: Cancer cell international
Published: July 06, 2025
Integration of genetic, proteomic, and transcriptomic data identifies therapeutic targets and prognostic biomarkers in bladder cancer.
Journal: Translational andrology and urology
Published: June 24, 2025
A female overactive bladder risk model developed by machine learning: based on 2007-2018 NHANES data.
Journal: Translational andrology and urology
Published: April 18, 2025
Comprehensive analysis of cholesterol metabolism-related genes in prostate cancer: integrated analysis of single-cell and bulk RNA sequencing.
Journal: Discover oncology
Published: November 28, 2024
Comparing the risk of cardiovascular disease between degarelix and gonadotropin-releasing hormone agonists:a systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: November 06, 2024
Prognostic value of circulating Chromogranin A in prostate cancer: a systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: November 02, 2024
DPH2 is a biomarker associated with cell death, immunity and prognosis based on pan-cancer analysis.
DPH2 is a biomarker associated with cell death, immunity and prognosis based on pan-cancer analysis.
Journal: Discover oncology
Published: October 28, 2024
A novel bone metastasis-related gene signature for predicting prognosis, anti-androgen resistance, and drug choice in prostate cancer.
Journal: Journal of bone oncology
Published: September 27, 2024
Prognostic value of programmed cell death ligand-1 expression in patients with bladder urothelial carcinoma undergoing radical cystectomy: A meta-analysis.
Journal: Frontiers in immunology
Published: July 05, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026